Kinpeygo is the first and only approved treatment for IgAN, a rare, progressive autoimmune disease of the kidney with a high unmet need, with more than 50% of patients potentially progressing to end-stage renal disease (ESRD)
Apple Delivered Much Better-Than-Feared ‘Jalen-Brunson-Like’ Quarter, Says Bullish Analyst: Why Betting Against Cupertino Is A ‘Wrong Move’
Apple's China troubles could soon be behind, likely helping resumption of growth, and the AI initiation will only serve to accelerate the momentum, says Daniel Ives.
